Insider Trading History of Khattar Jack A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Khattar Jack A. since 2019. This trader's CIK number is 1539937. At the time of last reporting, Khattar Jack A. was the President, CEO of Supernus Pharmaceuticals, Inc.. (stock ticker symbol SUPN). Also see all insider trading activities at Supernus Pharmaceuticals, Inc..

Note that in the past Khattar Jack A. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Scpharmaceuticals Inc. (SCPH) by Khattar Jack A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 SCPH 5,000 $19,570 0 $0 0 $0

Yearly summary of insider trading at Supernus Pharmaceuticals, Inc. (SUPN) by Khattar Jack A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SUPN 0 $0 177,300 $7,532,110 334,890 $4,217,556
2024 SUPN 0 $0 125,000 $4,536,250 181,000 $1,141,250
2023 SUPN 0 $0 19,944 $830,490 144,293 $315,888
2022 SUPN 0 $0 116,684 $3,795,411 248,269 $2,184,712
2019 SUPN 7,200 $189,979 0 $0 0 $0


Insider trading activities at 2 companies by Khattar Jack A.:

1. Scpharmaceuticals Inc. (SCPH)

2. Supernus Pharmaceuticals, Inc. (SUPN)

Table 1. Insider trading of Scpharmaceuticals Inc. (SCPH) by Khattar Jack A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-12-03 SCPH Buy 5,000 3.91 19,570

Table 2. Insider trading of Supernus Pharmaceuticals, Inc. (SUPN) by Khattar Jack A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-27 SUPN Option Ex 17,195 12.98 223,191
2025-08-28 SUPN Option Ex 38,779 12.98 503,351
2025-08-27 SUPN Sale 10,650 45.05 479,782
2025-08-28 SUPN Sale 24,150 45.12 1,089,648
2025-08-25 SUPN Option Ex 1,611 12.98 20,910
2025-08-25 SUPN Sale 1,000 45.00 45,000
2025-08-22 SUPN Sale 1,500 45.00 67,500
2025-08-22 SUPN Option Ex 2,415 12.98 31,346
2025-08-06 SUPN Sale 140,000 41.79 5,850,180
2025-08-06 SUPN Option Ex 201,250 17.09 3,438,758
2025-03-10 SUPN Option Ex 35,000 .00 0
2025-03-07 SUPN Option Ex 38,640 .00 0
2024-11-08 SUPN Option Ex 125,000 9.13 1,141,250
2024-11-08 SUPN Sale 125,000 36.29 4,536,250
2024-09-03 SUPN Option Ex 21,000 .00 0
2024-02-28 SUPN Option Ex 35,000 .00 0
2023-12-22 SUPN Option Ex 25,000 .00 0
2023-09-07 SUPN Option Ex 35,000 .00 0
2023-05-11 SUPN Option Ex 31,250 .00 0
2023-03-14 SUPN Option Ex 20,000 .00 0
2023-02-03 SUPN Sale 200 42.02 8,404
2023-02-02 SUPN Sale 13,532 42.05 569,088
2023-02-03 SUPN Option Ex 330 9.56 3,154
2023-02-02 SUPN Option Ex 22,515 9.56 215,243
2023-02-01 SUPN Option Ex 498 9.56 4,760
2023-02-01 SUPN Sale 300 42.01 12,602
2023-01-31 SUPN Option Ex 1,620 9.56 15,487
2023-01-31 SUPN Sale 976 42.01 41,002
2023-01-18 SUPN Option Ex 8,080 9.56 77,244
2023-01-18 SUPN Sale 4,936 40.40 199,394
2022-11-25 SUPN Sale 11,135 35.18 391,684
2022-11-25 SUPN Option Ex 17,794 9.56 170,110
2022-11-23 SUPN Sale 2,259 35.05 79,189
2022-11-23 SUPN Option Ex 3,616 9.56 34,568
2022-11-22 SUPN Option Ex 959 9.56 9,168
2022-11-22 SUPN Sale 600 35.00 21,001
2022-11-22 SUPN Option Ex 959 9.56 9,168
2022-11-22 SUPN Sale 600 35.00 21,001
2022-11-15 SUPN Option Ex 1,783 9.56 17,045
2022-11-15 SUPN Sale 1,115 35.00 39,028
2022-11-15 SUPN Option Ex 1,783 9.56 17,045
2022-11-15 SUPN Sale 1,115 35.00 39,028
2022-09-14 SUPN Option Ex 7,275 16.88 122,765
2022-08-16 SUPN Option Ex 48,712 17.01 828,444
2022-08-16 SUPN Sale 14,690 34.01 499,650
2022-08-15 SUPN Sale 17,302 34.03 588,752
2022-08-15 SUPN Option Ex 57,388 17.01 976,399
2022-08-10 SUPN Sale 28,437 31.22 887,803
2022-08-10 SUPN Option Ex 44,900 .00 0
2022-08-09 SUPN Sale 39,431 31.15 1,228,275
2022-08-09 SUPN Option Ex 63,100 .00 0
2019-08-23 SUPN Buy 7,200 26.39 189,979

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Khattar Jack A. (President, CEO of Supernus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.